Biomanufacturers should follow a risk-based approach to decide which methods to use to characterize their products.
Lisa Crossley, PhD
Advertisement
Lisa Crossley, PhD, is the founder and principal of BioVentures, Ontario, Canada, 888.405.9549.
Articles by Lisa Crossley, PhD
Advertisement
Latest Updated Articles
Protein Characterization Through the StagesPublished: August 2nd 2010 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
Industry Leaders Detail Transformational Strategies to Mainstream CAR-T Care
3
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
4
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
5
